홈 › 급성 골수성 백혈병 › 테네시
테네시의 급성 골수성 백혈병 임상 시험
급성 골수성 백혈병 관련 연구 31개가 테네시 내 여러 지역에서 참여자를 모집하고 있습니다.
테네시의 도시
공식 연구 텍스트(영어)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06317649Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Baptist Clinical Research Institute, Memphis
- Tennessee Oncology, Nashville
- TriStar Centennial Medical Center, Nashville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07007312Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
피험자 모집 중2상
18세 ~ 59세 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT05554406HPC Offered for PRESERVE Expansion
- Tristar Centennial Medical Center, Nashville
피험자 모집 중관찰 연구
12세 ~ 80세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07145411A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML
- Vanderbilt University Medical Center, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07751991A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- University of Tennessee, Knoxville
- Vanderbilt Ingram Cancer Center, Nashville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT06852222MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT05564390Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
피험자 모집 중2상
18세 ~ 59세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT05554393A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
- Saint Jude Children's Research Hospital, Memphis
피험자 모집 중1상
21세 이하 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07012044Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
- St. Jude Children's Research Hospital, Memphis
피험자 모집 중1상
1세 ~ 30세 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT06177067CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)
- Sarah Cannon Research Insitute, Nashville
피험자 모집 중1상
18세 ~ 85세 · 모든 성별 · 2026. 10. 21. 업데이트됨 · NCT06834282Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
- Sarah Cannon Center for Blood Cancer at TriStar Centennia, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT06846606A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Vanderbilt University Medical Center, Nashville
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 10. 6. 업데이트됨 · NCT04256317A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Tristar Centennial Medical Center /ID# 275831, Nashville
피험자 모집 중1상
6 Months – 17 Years · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT07306832A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- T C Thompson Children's Hospital, Chattanooga
- East Tennessee Childrens Hospital, Knoxville
- The Children's Hospital at TriStar Centennial, Nashville
- 외 1개
피험자 모집 중3상
6 Months – 21 Years · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT04293562A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia
- St. Jude Children's Research Hospital, Memphis
피험자 모집 중2상
29 Days – 21 Years · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT05955261A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
- St. Jude Children's Research Hospital, Memphis
피험자 모집 중1상
25세 이하 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06810583Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
- East Tennessee Childrens Hospital, Knoxville
- The Children's Hospital at TriStar Centennial, Nashville
피험자 모집 중3상
1세 ~ 25세 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07022678The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- East Tennessee Childrens Hospital, Knoxville
- Saint Jude Children's Research Hospital, Memphis
- The Children's Hospital at TriStar Centennial, Nashville
- 외 1개
피험자 모집 중1/2상
22세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04726241Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Vanderbilt University Medical Center, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT06001788Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
- Baptist Health Care Corporation, Memphis
- Vanderbilt University/Ingram Cancer Center, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT06399640Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Vanderbilt University, Ingram Cancer Center, Nashville
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT07216443A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- St. Jude Childrens Research Hospital, Memphis
- Vanderbilt University, Nashville
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT01351545Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
- St. Jude Children's Research Hospital, Memphis
피험자 모집 중1상
21세 이하 · 모든 성별 · 2026. 4. 22. 업데이트됨 · NCT05101551A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- TriStar Centennial Medical Center, Nashville
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 3. 24. 업데이트됨 · NCT04988555A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
- Sarah Cannon Cancer Institute, Nashville
- Vanderbilt University Medical Center, Nashville
피험자 모집 중1상
12세 이상 · 모든 성별 · 2026. 3. 16. 업데이트됨 · NCT06994676A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
- TriStar Bone Marrow Transplant, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 3. 13. 업데이트됨 · NCT05735184A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
- Vanderbilt University, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 9. 업데이트됨 · NCT06950034CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
- St. Jude Children's Research Hospital, Memphis
피험자 모집 중1상
21세 이하 · 모든 성별 · 2026. 1. 23. 업데이트됨 · NCT06326463A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
- Sarah Cannon Research Institute, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2025. 9. 24. 업데이트됨 · NCT06501196Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
- TriStar Bone Marrow Transplant, Nashville
피험자 모집 중1상
18세 이상 · 모든 성별 · 2024. 11. 15. 업데이트됨 · NCT06034275ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.